Search

Your search keyword '"M. Mielcarek"' showing total 201 results

Search Constraints

Start Over You searched for: Author "M. Mielcarek" Remove constraint Author: "M. Mielcarek"
201 results on '"M. Mielcarek"'

Search Results

1. Dialkylcarbamoyl chloride‐coated versus alginate dressings after pilonidal sinus excision: a randomized clinical trial (SORKYSA study)

2. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

3. Hierarchical superparamagnetic metal–organic framework nanovectors as anti-inflammatory nanomedicines

5. Tuberculose multirésistante : une prise en charge qui pèse lourd aux hôpitaux universitaires de Strasbourg

6. [Digital eye strain. Functional symptoms and binocular balance analysis in intensive digital users]

7. Biostatistiques médicales avec GMRC Shiny Stats - un outil de formation par la pratique

8. [Medical biostatistics with GMRC Shiny Stats - learning by doing]

9. 740P Response assessment in advanced renal cell carcinoma (mRCC) patients (pts) treated by Nivolumab (N) + Ipilimumab (I): CT volumetric measurement versus RECIST 1.1 response criteria

10. [Multidrug-resistant tuberculosis: A management problem that weighs heavily on the University Hospitals of Strasbourg]

11. Bacteriological quality evaluation of bedpans in a university hospital

12. Silicate-, aluminosilicate and calciumsilicate gels for building materials: chemical and mechanical properties during ageing

13. Bone marrow transplantation and graft versus host disease (PP-077)

14. Weakening of Alkali-Activated Metakaolin During Aging Investigated by the Molybdate Method and Infrared Absorption Spectroscopy

15. Outcomes of Allogeneic Hematopoietic Stem Cell Recipients Diagnosed With Invasive Fungal Infection Prior to Transplant Procedure

17. The Ageing Process of Alkali Activated Metakaolin

18. Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease

19. Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation

20. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells

23. Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trials.

24. COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics.

25. The Effect of Gastrointestinal Graft-Versus-Host Disease and Diarrhea on the Pharmacokinetic Profile of Sotrovimab in Hematopoietic Stem Cell Transplant Recipients.

27. Clinical Insights and Potential Benefits of Stem Cell Transplantation for Constitutional Mismatch Repair Deficiency: A Case Report of Two Siblings.

28. Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization.

29. The Kinetics of Inflammation-Related Proteins and Cytokines in Children Undergoing CAR-T Cell Therapy-Are They Biomarkers of Therapy-Related Toxicities?

30. Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre-Cellular Therapy SARS-CoV-2 Infection.

31. Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting Diabetes.

32. Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients.

33. Deregulated Transcriptome as a Platform for Adrenal Huntington's Disease-Related Pathology.

34. Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial.

35. Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

36. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.

37. Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.

38. Revisiting the Utility of Granulocyte Colony-Stimulating Factor Post-Autologous Hematopoietic Stem Cell Transplantation for Outpatient-Based Transplantations.

39. Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation.

40. A minimal region of the HSP90AB1 promoter is suitable for ubiquitous expression in different somatic tissues with applicability for gene therapy.

41. Effective treatment of low-risk acute GVHD with itacitinib monotherapy.

42. NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.

43. Late Effects of Severe Acute Graft-versus-Host Disease on Quality of Life, Medical Comorbidities, and Survival.

44. Blinatumomab Prior to CAR-T Cell Therapy-A Treatment Option Worth Consideration for High Disease Burden.

45. The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder.

46. Identification of the Transcriptional Biomarkers Panel Linked to Pathological Remodelling of the Eye Tissues in Various HD Mouse Models.

47. Structural Abnormalities of the Optic Nerve and Retina in Huntington's Disease Pre-Clinical and Clinical Settings.

48. [Digital eye strain. Functional symptoms and binocular balance analysis in intensive digital users].

49. Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipients.

50. Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings.

Catalog

Books, media, physical & digital resources